Start the conversation
According to the U.S. Centers for Disease Control (CDC), the seven-day moving average of COVID-19 related hospitalizations has fallen 74%, from a January peak exceeding 122,500 to just more than 32,300 reported last week.
But despite the progress on the novel coronavirus, hospitals – still working 24/7 to save tens of thousands of lives – still haven't been able to catch a break.
Hundreds of them, maybe even more, have found themselves under siege by a very different kind of "virus."
I'm talking about ransomware. Hospitals and medical systems are the target of choice for hackers who burrow into networks and take control.
The reasons for this are very disturbing, and the impact is devastating – I'll show you in a moment.
But there's great news: A global, first-tier cybersecurity firm is working on a range of solutions to minimize and ultimately eliminate these costly cybercrimes. That's one of the reasons why I'm projecting this company will double its earnings by 2024.
You have to move quickly on this one, though; it's in the midst of a buying opportunity the likes of which we haven't seen since late 2020, and there are signs it's about to begin its next leg up…
How and Why Hackers Target Hospitals Specifically
Once they get in and take control, hackers steal sensitive information to use for their own nefarious purposes, or, very often, sell to the highest dark-web bidders. Oftentimes, they encrypt the targeted data and hold it "hostage" for ransom. Victims, totally locked out of their computer systems, are presented with a stark choice: pay hundreds of thousands of dollars to decrypt the hostage data and regain access… or lose it forever.
PAYDAY APPOINTMENTS – all it takes is a couple of them to start collecting big profits. Tom Gentile can show you how to schedule EIGHT of them on your calendar this month. See how this works here.
The demands depend on the target. An individual might be shaken down for $500 or $1,000. A big institution like a hospital or local government might be asked for $1 million or more.
Just this past weekend, in a situation that's still developing, Acer Inc., a Taiwanese computer and electronics giant, was attacked and walloped with a record-high demand for US$50 million. If Acer doesn't pay by March 28, it's reported the crooks will double their ransom demand to $100 million.
During the pandemic, the attacks on hospitals intensified; as the stakes grew higher for patients and hospitals, criminal hackers upped their demands accordingly. According to Coveware, a company that helps negotiate with hackers, more ransomware attacks were made against healthcare in the fourth quarter of 2020 than any other industry.
The reasons are clear. Healthcare today is almost completely digitized. Medical records, lab results, scans, prescriptions – it's all stored electronically. There are interconnected medical devices on the "Internet of Things" (IoT), as well. This all makes work much easier for the physicians, nurses, and techs who deal with it all, and it helps improve patient outcomes.
Unfortunately, it also makes healthcare a prime target for hackers.
In 2019 alone, the last year for which complete data is available, there were more than 760 such ransomware attacks on the healthcare sector. In light of Coveware's report, it stands to reason that figure increased dramatically in 2020 and continues to run high.
There's not much hard data on who choses to pay and who doesn't; organizations can be reluctant to publicly discuss these things. But there's some anecdotal evidence that suggests not paying the ransom can, in some cases, prove much more expensive.
SMALL CRYPTOS: There are three under-the-radar names priced under $10 we think every investor should know about. Details here…
Universal Health Services in King of Prussia, Pennsylvania, was hit with a ransomware attack this past September. Management refused to cave in; IT specialists replaced the computer systems.
That October, Sky Lakes Medical Center in Klamath Falls, Ore., had to completely shut down its computer network overnight to avoid losing everything to a ransomware attack. Electronic medical records, prescriptions, test results, MRI scans – everything was stored on those computers, and at the flip of a switch, it all became inaccessible.
Sky Lakes Medical Center restored its systems fully a month later – while dealing with spiking COVID-19 cases. It had to completely replace 2,500 computers and rebuild its network.
The cost to Universal Health Services was an estimated $67 million in lost revenue, labor, and new systems; Sky Lakes paid nearly $10 million to repair the problem.
That's where today's pick comes in. It's a leader in the $140 billion cybersecurity sector – a sector Fortune Business Insights estimates will grow 12.6% a year to $281.7 billion by 2027.
Almost Everything Depends on Cybersecurity
Palo Alto Networks Inc. (NASDAQ: PANW) offers a vast suite of security tools used by large organizations all over the world, including, increasingly, healthcare providers.
Palo Alto makes secured network hardware and software, and it deploys artificial intelligence (AI) to scour a company's physical and Cloud-based infrastructure for unusual activity and other signs of hacker intrusion.
Palo Alto doubled its Prisma Access subscriber headcount over the past year, to the point where a full third of Fortune 100 companies use Palo Alto's Prisma Access platform to secure their Cloud operations. Its Cortex cloud cybersecurity AI is even more popular – two-thirds of the Fortune 100 use that platform.
The Cortex AI recently even thwarted a hack on Palo Alto itself.
Clearly, Prisma Access and Cortex are two standout products and a huge reason why Palo Alto Networks' 1,800-plus clients yielded $4.3 billion in revenue in 2020, up 23% year over year.
But monitoring the way apps access networks can only do so much. As the recent SolarWinds hack showed, criminal network intruders are increasingly moving down the supply chain. Instead of hacking networks directly, they're attacking the developers or chip makers that create the apps and hardware that make up those networks.
That way, the hack is "built in" to the network from the start, vastly more difficult to discover.
That's why Palo Alto is moving to have its Prisma Cloud also secure the development and operations process of setting up networks to begin with. To do so, the firm just announced its acquisition of Bridgecrew, a cybersecurity company focused on securing developers, for $156 million.
CRYPTO GUIDE: It's never been easier to take a shot at huge profit potential on tiny, lesser-known "altcoins." Learn more about how to start right here…
Bridgecrew's network-design scanner was released last year and has already been downloaded over 1 million times.
By integrating Bridgecrew's developer-focused security scans into Prisma Cloud, Palo Alto will have the world's first cybersecurity platform that can secure a network from design through operations.
Despite those huge strides, I still see plenty of upside ahead. In its most recent earnings report, Palo Alto revealed a 25% jump in revenue and a 30% jump in adjusted earnings per share, roughly double its three-year average.
After having looked through its financials, I'm projecting earnings growth of 24% a year, meaning it will double in roughly three years.
Incredibly, PANW shares are "on sale" right now, at compelling prices. The stock has been caught up in the broader weakness holding the tech sector down right now; there's also been a boardroom shakeup and a new chief financial officer appointed.
Palo Alto stock is down nearly 21% from its February highs and trading at prices we haven't seen since the middle of December. The shares have been consolidating for about a week now and, just yesterday, resumed what's likely to be a short trip back to all-time highs and beyond.
Palo Alto Networks is just one of the high-profit potential stocks I've researched for my Nova-X Report subscribers, but one of the most exciting investments I'm watching right now are small, specific-use cryptocurrencies. These can be based on Bitcoin technology, but they can sometimes make even bigger moves. I'm researching three right now in what I call the "Digital Gold Rush of the 21st Century." You can click right here to learn more about those.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.